Synairgen (LON:SNG) Stock Price Up 22% – Time to Buy?

Synairgen plc (LON:SNG)’s stock price shot up 22% on Wednesday . The company traded as high as GBX 2.71 ($0.03) and last traded at GBX 2.68 ($0.03). 1,771,337 shares changed hands during trading, an increase of 25% from the average session volume of 1,421,729 shares. The stock had previously closed at GBX 2.20 ($0.03).

Synairgen Price Performance

The company has a quick ratio of 6.35, a current ratio of 6.77 and a debt-to-equity ratio of 0.09. The firm’s fifty day moving average price is GBX 3.60 and its 200-day moving average price is GBX 3.96. The stock has a market cap of £3.69 million, a P/E ratio of -61.03 and a beta of -2.23.

About Synairgen

Synairgen is a respiratory drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic. The business, focused primarily on lung viral defence in asthma and COPD, uses its differentiating human biology BioBank platform and world-renowned international academic KOL network to discover and develop novel therapies for respiratory disease.

Synairgen is conducting a double blind, placebo-controlled clinical trial in COVID-19 patients (SG016).